Skip to main content
. 2016 Feb 22;79(4):675–679. doi: 10.1021/acs.jnatprod.5b01016

Figure 2.

Figure 2

In vitro cell-protective effects of B-ring dioxane and B-ring pyran bryostatin analogues against CHIKV (full structure provided in Figure 1). aSee Figure 1 for a description of EC50 and CC50 values; standard deviations for all values can be found in the Supporting Information. bNote that bryostatin 1 (1) contains a slightly different southern fragment than the analogues above, namely, the C-20 octadienoate (rather than octanoate) and the presence of a C-26 methyl group. cValues in italics indicate that toxicity was observed before the EC50 value could be generated.